Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview - 18/06/20
pages | 10 |
Iconographies | 5 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | Polydatin is a monocrystal-line compound purified from Polygonum cuspidatum. |
• | Polydatin has effects on multiple systems, especially the cardiovascular system. |
• | Polydatin treats AS mainly from anti-inflammatory, and anti-oxidative stress. |
• | Polydatin can act in the entire process of reverse cholesterol transport. |
• | This review also covers the toxicology and pharmacokinetics of polydatin. |
Abstract |
With the advancement of science and technology, the living standards of human beings have continuously improved, but the incidence and mortality from atherosclerosis worldwide have also increased by year. Although interventional surgery and the continuous development of new drugs have significant therapeutic effects, their side effects cannot be ignored. Polydatin, an active ingredient isolated from the natural medicine Polygonum cuspidatum, has been shown to have a prominent role in the treatment of cardiovascular diseases. Polydatin treats atherosclerosis mainly from three aspects: anti-inflammatory, regulating lipid metabolism and anti-oxidative stress. This article will review the pharmacological mechanism of polydatin in anti-atherosclerosis, the biological characteristics of Polygonum cuspidatum, the toxicology and pharmacokinetics of polydatin and will provide ideas for further research.
Le texte complet de cet article est disponible en PDF.Keywords : Polydatin, Polygonum cuspidatum, Atherosclerosis, Anti-Inflammatory, Anti-Oxidative stress
Plan
Vol 128
Article 110308- août 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?